Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
US Army
US Department of Justice
Novartis
Colorcon
Medtronic
Express Scripts
Daiichi Sankyo
Deloitte

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084710

« Back to Dashboard

NDA 084710 describes OGEN, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. Additional details are available on the OGEN profile page.

The generic ingredient in OGEN is estropipate. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the estropipate profile page.
Summary for 084710
Tradename:OGEN
Applicant:Pharmacia And Upjohn
Ingredient:estropipate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;VAGINALStrength1.5MG/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Farmers Insurance
Teva
US Department of Justice
Covington
Fuji
Johnson and Johnson
Express Scripts
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot